Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Xarelto
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xarelto 20mg tablets
0208020Y0BBACAC
|
Xarelto | Rivaroxaban | Cardiovascular System | 2,929 |
|
Xarelto 15mg tablets
0208020Y0BBABAB
|
Xarelto | Rivaroxaban | Cardiovascular System | 615 |
|
Xarelto 10mg tablets
0208020Y0BBAAAA
|
Xarelto | Rivaroxaban | Cardiovascular System | 462 |
|
Xarelto 2.5mg tablets
0208020Y0BBADAD
|
Xarelto | Rivaroxaban | Cardiovascular System | 103 |
|
Xarelto 1mg/ml granules for oral suspension
0208020Y0BBAFAF
|
Xarelto | Rivaroxaban | Cardiovascular System | 17 |
|
Xarelto 15mg/20mg treatment initiation pack
0208020Y0BBAEAE
|
Xarelto | Rivaroxaban | Cardiovascular System | 8 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.